LUMOS PHARMA, INC. Quarterly Income Tax Expense (Benefit) in USD from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Lumos Pharma, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2012 to Q3 2024.
  • Lumos Pharma, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • Lumos Pharma, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $0.000.
  • Lumos Pharma, Inc. annual Income Tax Expense (Benefit) for 2023 was -$29K, a 123% decline from 2022.
  • Lumos Pharma, Inc. annual Income Tax Expense (Benefit) for 2022 was -$13K, a 98% increase from 2021.
  • Lumos Pharma, Inc. annual Income Tax Expense (Benefit) for 2021 was -$636K, a 95.4% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $0 $0 $0 Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $0 $0 +$29K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 -$29K $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$29K $0 +$13K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 -$42K $0 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$42K -$29K -$29K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 -$13K $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$13K -$13K +$623K +98% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$636K $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$636K $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$636K $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 -$636K -$636K +$13.4M +95.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 -$14M $0 +$2.43M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$16.4M $0 +$1.43M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$17.9M $0 +$5.46M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$23.3M -$14M -$14M Oct 1, 2020 Dec 31, 2020 10-K 2021-03-09
Q3 2020 -$9.32M -$2.43M -$2.43M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$6.89M -$1.43M -$1.43M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$5.46M -$5.46M -$5.46M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $0 $0 -$23K -100% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 $23K $0 +$6.99M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$6.97M $0 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$6.97M $0 $0 Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-02
Q4 2018 -$6.97M $23K +$153K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-03
Q3 2018 -$7.12M -$6.99M -$6.87M -5775% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$249K $0 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$249K $0 +$310K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$559K -$130K +$510K +79.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-03
Q3 2017 -$1.07M -$119K +$1.19M +90.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 -$2.26M $0 +$2.08M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 -$4.34M -$310K +$1.32M +81% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 -$5.66M -$640K -$7.38M -109% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-05
Q3 2016 $1.72M -$1.31M -$1.47M -918% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $3.19M -$2.08M -$250K -13.7% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $3.44M -$1.63M -$3.3M -198% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $6.74M $6.74M -$22.3M -76.8% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-05
Q3 2015 $29M $160K +$7.57M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $21.5M -$1.83M -$1.83M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $23.3M $1.67M +$1.67M Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-29
Q4 2014 $21.6M $29M +$28.9M +22230% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-06
Q3 2014 -$7.28M -$7.41M -$7.41M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $130K $0 $0 Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 $130K $0 $0 Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-08-24
Q4 2013 $130K $130K Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $0 Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $0 Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $0 $0 Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q1 2012 $0 Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.